GBS appoints Chairman Steven Boyages as Interim CEO; Harry Simeonidis moves to President APAC

INTELLIGENT BIO SOLUTIONS INC.

Chairman Steven Boyages, MD PhD, appointed Interim CEO effective Oct 29, 2021; no additional compensation.
Harry Simeonidis resigned as CEO, President, and Board member; stays as President Asia Pacific, Sales & Marketing.
Board initiates search for permanent CEO via leading executive search firm.
No disagreements between Company and Mr. Simeonidis related to operations, policies, or practices.
Boyages has extensive healthcare executive experience, including 9 years as CEO of Sydney West Area Health Service.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Harry Simeonidis

President Asia Pacific, Sales and Marketing

INBS · INTELLIGENT BIO SOLUTIONS INC.

Effective: 2021-10-29
Successor: Steven Boyages
Filed: November 3, 2021, 7:59 PM ET

Harry Simeonidis, who served as CEO and President of the Company, vacated these positions prior to Professor Boyages’ appointment as Interim CEO and was appointed to the position of President Asia Pacific, Sales and Marketing, effective October 29, 2021.

Appointed (interim)

Steven Boyages

Interim Chief Executive Officer

INBS · INTELLIGENT BIO SOLUTIONS INC.

Effective: 2021-10-29
Filed: November 3, 2021, 7:59 PM ET

the board of directors (the “Board”) of GBS Inc. (the “Company”) appointed Professor Steven Boyages, the Chairman of the Board, to the additional position of Interim Chief Executive Officer of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Harry Simeonidis was appointed as President Asia Pacific, Sales and Marketing at INTELLIGENT BIO SOLUTIONS INC..

Action: appointed
Role: President Asia Pacific, Sales and Marketing

Exact text from the filing

Harry Simeonidis, who served as CEO and President of the Company, vacated these positions prior to Professor Boyages’ appointment as Interim CEO and was appointed to the position of President Asia Pacific, Sales and Marketing, effective October 29, 2021.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven Boyages was appointed as Interim Chief Executive Officer at INTELLIGENT BIO SOLUTIONS INC..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

the board of directors (the “Board”) of GBS Inc. (the “Company”) appointed Professor Steven Boyages, the Chairman of the Board, to the additional position of Interim Chief Executive Officer of the Company, effective immediately.

View on SEC.gov

INTELLIGENT BIO SOLUTIONS INC. filing history →

Source: SEC EDGAR

accession 0001493152-21-027125

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.